✦ LIBER ✦

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

✍ Scribed by Kristian Reich; Frank O Nestle; Kim Papp; Jean-Paul Ortonne; Robert Evans; Cynthia Guzzo; Shu Li; Lisa T Dooley; Christopher EM Griffiths

Book ID: 117290399
Publisher: The Lancet
Year: 2005
Tongue: English
Weight: 320 KB
Volume: 366
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)67566-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab induction therapy for patient

Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial

✍ Alice B. Gottlieb; Robert Evans; Shu Li; Lisa T. Dooley; Cynthia A. Guzzo; Danie 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Adalimumab therapy for moderate to sever

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

✍ Alan Menter; Stephen K. Tyring; Kenneth Gordon; Alexa B. Kimball; Craig L. Leona 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 653 KB

Improvement in quality of life with infl

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial

✍ K. Reich; F.O. Nestle; K. Papp; J.-P. Ortonne; Y. Wu; M. Bala; R. Evans; C. Guzz 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Long-term efficacy and safety of mainten

Long-term efficacy and safety of maintenance versus intermittent infliximab therapy for moderate to severe plaque-type psoriasis: The RESTORE2 trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Infliximab monotherapy in Japanese patie

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial

✍ Torii, Hideshi; Nakagawa, Hidemi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Oral pimecrolimus in the treatment of mo

Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial

✍ A.B. Gottlieb; C.E.M. Griffiths; V.C. Ho; M. Lahfa; U. Mrowietz; D.F. Murrell; J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB